Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000253571 | SCV000307296 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000253571 | SCV000721423 | likely benign | not specified | 2017-07-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000697368 | SCV000825973 | benign | Nemaline myopathy 2 | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003133201 | SCV003813578 | uncertain significance | not provided | 2019-04-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000697368 | SCV001460598 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |